About the Company
Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines. In 2022, a split of PerkinElmer resulted in one part, comprising its applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but keeping the PerkinElmer name. The other part, comprising the life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc. From the perspective of Revvity, the goal of creating a separate company was that its businesses might show greater profit margins and more in the way of growth potential. An associated goal was to have more financial flexibility moving forward. On May 16, 2023, the PerkinElmer stock symbol PKI was replaced by the new symbol RVTY. The name 'Revvity' itself was formed from a combination of the words "revolution" (abrupt change, in English) and "vita" (life, in Latin). It was the larger of the two splitees: of around 17,000 employees of the public PerkinElmer, about 11,000 of them were assigned to it, while some 6,000 went to the newly private PerkinElmer. Initial annual revenues for Revvity were estimated at about $3 billion. Singh and some other senior executives came to Revvity from PerkinElmer, while others were new hires. Headquarters for Revvity were kept in the same town as the old PerkinElmer, that being Waltham, Massachusetts. Compared with its PerkinElmer past, Revvity was de-emphasizing medical devices in favor of an approach based on reagents and electronic commerce.
Sector
Industrial Applications and Services
Industry
Laboratory Analytical Instruments
Employees
13000
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on REVVITY, INC.
Revvity, Inc. (NYSE:RVTY) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript July 28, 2025 Revvity, Inc. misses on earnings expectations. Reported EPS is $0.459 EPS, expectations were $1.14. Operator: Hello, everybody, and welcome to the Q2 ...
Revvity Launches Innovative Reagent Technology to Accelerate Development of Next-Generation Targeted Therapeutics
Revvity, Inc. (NYSE: RVTY), today announced the launch of pHSense™ reagents, a powerful technology designed to advance ...
Revvity Inc. stock underperforms Tuesday when compared to competitors despite daily gains
Revvity Inc. closed 32.05% below its 52-week high of $129.50, which the company reached on November 6th.
Reasons to Retain Revvity Stock in Your Portfolio for Now
Revvity, Inc. RVTY is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by its solid second-quarter 2024 performance and focus on ...
Revvity Inc. stock outperforms competitors on strong trading day
Revvity Inc. closed 29.90% below its 52-week high of $129.50, which the company achieved on November 6th.
Revvity, Inc. (NYSE:RVTY) Shares Bought by O Shaughnessy Asset ...
O Shaughnessy Asset Management LLC lifted its position in shares of Revvity, Inc. (NYSE:RVTY – Free Report) by 19.0% during the fourth quarter, according to the company in its most recent Form ...
What's Going On With Revvity Stock Today? - Revvity (NYSE:RVTY)
Revvity’s Auto-Pure 2400 platform, approved by the FDA, enhances high-throughput latent TB testing with improved accuracy. RVTY stock rises after FDA approval, boosting lab productivity and ...
Commit To Buy Revvity At $115, Earn 11.3% Annualized Using Options - Nasdaq
Investors considering a purchase of Revvity Inc (Symbol: RVTY) shares, but tentative about paying the going market price of $121.26/share, might benefit from considering selling puts among the ...
Revvity, Inc. (NYSE:RVTY) Shares Acquired by Nuveen Asset Management ...
Revvity, Inc. has a fifty-two week low of $88.53 and a fifty-two week high of $129.50. The stock’s fifty day moving average is $97.62 and its two-hundred day moving average is $109.81.
Revvity Inc (RVTY) Q2 2025 Earnings Call Highlights: Strong Software ...
Revvity Inc (NYSE:RVTY) lowered its full-year organic growth outlook to 2% to 4%, down 1% from prior expectations. The company anticipates a meaningful pullback in its Immunodiagnostics business ...
Revvity: Enter Now As Reorganization Takes Shape
Mar. 21, 2024 11:27 AM ET Revvity, Inc. (RVTY) Stock TCHBF, TMO, DHR A QGEN TECH CTKB BRKR TCGGY TMO:CA RVTY 4 Comments 3 Likes Another Mountain's Rock Investing 2.82K Follower s ...
Revvity, Inc. (RVTY) Q3 2023 Earnings Call Transcript
Revvity, Inc. (NYSE: RVTY) Q3 2023 Earnings Conference Call October 30, 2023 8:00 AM ET Company Participants Steve Willoughby - Senior Vice President Investor Relations Prahlad Singh - President ...
Similar Companies
Loading the latest forecasts...